Environmental determinants of ketamine's prohedonic and antianhedonic efficacy: Persistence of enhanced reward responsiveness is modulated by chronic stress.

Saved in:
Bibliographic Details
Title: Environmental determinants of ketamine's prohedonic and antianhedonic efficacy: Persistence of enhanced reward responsiveness is modulated by chronic stress.
Authors: Jenkins AR; Harvard Medical School, McLean Hospital, Belmont, Massachusetts., Radl DB; Neurocrine Biosciences, Inc, San Diego, California., Kornecook TJ; Neurocrine Biosciences, Inc, San Diego, California., Pizzagalli DA; Harvard Medical School, McLean Hospital, Belmont, Massachusetts., Bergman J; Harvard Medical School, McLean Hospital, Belmont, Massachusetts., Buhl DL; Takeda Pharmaceuticals, Cambridge, Massachusetts., O'Donnell P; Takeda Pharmaceuticals, Cambridge, Massachusetts., Kangas BD; Harvard Medical School, McLean Hospital, Belmont, Massachusetts. Electronic address: bkangas@mclean.harvard.edu.
Source: The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2025 May; Vol. 392 (5), pp. 103572. Date of Electronic Publication: 2025 Apr 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0376362 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1521-0103 (Electronic) Linking ISSN: 00223565 NLM ISO Abbreviation: J Pharmacol Exp Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1521-0103
DOI:10.1016/j.jpet.2025.103572